| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/28/2009 | US7524643 Nucleotide sequences coding voltage gated calcium channels (VGCC) for treating neurological and cardiovascular disorders; anticonvulsant |
| 04/28/2009 | US7524638 Methods for identification of modulators of OSGPR114 or OSGPR78 activity, and their use in the treatment of disease |
| 04/28/2009 | US7524637 Nucleotide sequences coding g protein coupled receptors for identifying compounds block or enhance taste perception; food processing; improving taste of pharmeceuticals |
| 04/28/2009 | US7524634 In gastric cancer and related cancers, a higher expression of CA IX indicates poorer prognosis for afflicted patients, particularly when expressed at the invasion front of the cancer |
| 04/28/2009 | US7524627 Contains connecting disulfide bridge; humanized monoclonal and polyclonal antibodies; generating and/or increasing an immunogenic response directed against Respiratory Syncytial Virus |
| 04/28/2009 | US7524624 Using druggable regions to screen potential candidate therapeutics for diseases caused by viruses having class II E proteins; viral fusion inhibitors |
| 04/28/2009 | US7524622 Lectin-like transcript (LLTI); Natural killer cells; antitumor agents; quantitative analysis; human lectin transcription factor |
| 04/28/2009 | US7524508 Contain large deletions; vaccines against dengue virus infection; structural proteins encapsulate said subgenomic replicon |
| 04/28/2009 | US7524506 gM-negative EHV-mutants without heterologous elements |
| 04/28/2009 | US7524505 Cell growth factor of hair stem cell factor induces migration of melanocyte stem cells and keratinocyte stem cells to increase in hair follicles, amino acids and vitamins, and minoxidil |
| 04/28/2009 | US7524503 Antigens; vaccines; isolated peptide |
| 04/28/2009 | US7524499 Vascular endothelial growth factor fusion comprising fms-related tyrosine kinase 1 (Flt1 receptor ) and immunoglobulin components for use in identifying modulators for decreasing or inhibiting plasma leakage; treating eye disorders |
| 04/28/2009 | US7524497 Genetic engineering; oligonucleotide detector; identification and isolation of novel DNA; transmembrane domain-deleted or transmembrane domain-inactivated protein; soluble extracellular domains; PRO polypeptide |
| 04/28/2009 | US7524495 Inhibition of TACE or amphiregulin for the modulation of EGF receptor signal transactivation |
| 04/28/2009 | US7524493 Nucleic acid constructs cells transformed therewith and methods utilizing same for inducing liver regeneration and alleviation of portal hypertension |
| 04/28/2009 | US7524492 Insulin related transcription factor and uses thereof |
| 04/28/2009 | US7524488 Interleukin-18 mutants |
| 04/28/2009 | CA2418506C Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases |
| 04/28/2009 | CA2219988C Cd16-ii variants |
| 04/28/2009 | CA2197653C Delivery of nucleic acids |
| 04/28/2009 | CA2191978C Novel bacillus thuringiensis genes coding toxins active against lepidopteran pests |
| 04/28/2009 | CA2133017C Process for producing desired substance using acetic acid-resistant recombinant escherichia microorganism |
| 04/28/2009 | CA2107856C Detection of antibiotics |
| 04/28/2009 | CA1341595C Procedure for obtaining dna, rna, peptides, polypeptides, or proteins byrecombinant dna techniques |
| 04/23/2009 | WO2009052476A2 Maize stress-responsive nac transcription factors and promoter and methods of use |
| 04/23/2009 | WO2009052392A1 Immunoassays and kits for the detection of ngal |
| 04/23/2009 | WO2009052390A1 Glycosylated mammalian ngal and use thereof |
| 04/23/2009 | WO2009052374A2 Igm-mediated receptor clustering and cell modulation |
| 04/23/2009 | WO2009052323A2 Manufacture, compositions and uses of coagulationfactor viia modulator |
| 04/23/2009 | WO2009052242A2 Axmi-066 and axmi-076: delta-endotoxin proteins and methods for their use |
| 04/23/2009 | WO2009052221A2 Methods for extracting platelets and compositions obtained therefrom |
| 04/23/2009 | WO2009052184A2 Compositions comprising optimized her1 and her3 multimers and methods of use thereof |
| 04/23/2009 | WO2009052179A2 Feline pancreatic lipase |
| 04/23/2009 | WO2009051846A2 Translocation and mutant ros kinase in human non-small cell lung carcinoma |
| 04/23/2009 | WO2009051844A1 Synthetic analogues of neural regeneration peptides |
| 04/23/2009 | WO2009051827A1 Modulation of sodium channels by nicotinamide adenine dinucleotide |
| 04/23/2009 | WO2009051717A2 Human factor ix variants with an extended half life |
| 04/23/2009 | WO2009051555A2 Modified mhc class i binding peptides |
| 04/23/2009 | WO2009051277A1 Method for prediction of postoperative prognosis, and diagnosis kit |
| 04/23/2009 | WO2009051226A1 Method for production of stable mutant protein |
| 04/23/2009 | WO2009050573A2 Viral modification of reoviridae |
| 04/23/2009 | WO2009050474A1 Immunogenic ompositions containing escherichia coli h7 flagella and methods of use thereof |
| 04/23/2009 | WO2009050453A2 Breast cancer associated antigen |
| 04/23/2009 | WO2009050446A1 Viral therapeutic |
| 04/23/2009 | WO2009050319A1 Scalable process for producing phycocyanine |
| 04/23/2009 | WO2009050309A1 Isoforms of human somatostatin receptor type 5 produced by alternative processing and oligonucleotide pairs for detection thereof by pcr |
| 04/23/2009 | WO2009050279A1 Peptides based on the sequence of human lactoferrin and their use |
| 04/23/2009 | WO2009050275A1 A protease-sensitive site in apolipoprotein a1, therapeutic and diagnostic implications |
| 04/23/2009 | WO2009050267A2 Il24 for inducing hyperproliferative or autoimmune cell death |
| 04/23/2009 | WO2009050266A2 Use of n-terminal and c-terminal proteomics technology to enhance protein therapeutics and diagnostics |
| 04/23/2009 | WO2009050022A1 Novel protein variants by circular permutation |
| 04/23/2009 | WO2009049892A1 Polypeptides comprising an annexin core domain, compositions, methods and use thereof |
| 04/23/2009 | WO2009049881A1 Soluble gp130 muteins with improved binding activity |
| 04/23/2009 | WO2009049635A1 Novel molecules and mechanism for therapy |
| 04/23/2009 | WO2009032664A3 Methods and compositions for increasing biological molecule stability |
| 04/23/2009 | WO2009032456A3 Non-viral delivery of transcription factors that reprogram human somatic cells into a stem cell-like state |
| 04/23/2009 | WO2009030483A3 Calcium phosphate based delivery of growth and differentiation factors to compromised bone |
| 04/23/2009 | WO2009024620A3 A process for isolation and purification of a target protein free of prion protein (prpsc) |
| 04/23/2009 | WO2009020459A3 Glucanases, nucleic acids encoding them and methods for making and using them |
| 04/23/2009 | WO2009010765A3 Lantibiotic-based compounds having antimicrobial activity |
| 04/23/2009 | WO2009009019A3 Treatment and diagnostic methods for fibrosis related disorders |
| 04/23/2009 | WO2009008756A4 DNA SEQUENCE ENCODING A SPECIFIC L-ARABINOSE TRANSPORTER, A cDNA MOLECULE, A PLASMID COMPRISING THE SAID DNA SEQUENCE, HOST CELL TRANSFORMED WITH SUCH PLASMID AND APPLICATION THEREOF |
| 04/23/2009 | WO2008156428A3 Novel peptides and protein and uses thereof |
| 04/23/2009 | WO2008151633A3 Vectors for vaccines against lentivirus infections |
| 04/23/2009 | WO2008148575A3 Increased production of a target product via stabilization of mrna |
| 04/23/2009 | WO2008121435A3 Methods for generating novel stabilized proteins |
| 04/23/2009 | WO2008115710A3 Biomarkers for cancer |
| 04/23/2009 | WO2008095995A8 Peptidic and non peptidic ligands for immunodetection of the receptor for urotensin ii |
| 04/23/2009 | WO2008038287A3 N-terminal fgf variants having increased receptor selectivity and uses thereof |
| 04/23/2009 | WO2007055966A3 Therapies for cancer using rlip76 |
| 04/23/2009 | WO2007047988A3 Chimeric human sweet-umami and umami-sweet taste receptors |
| 04/23/2009 | WO2007046893A3 Methods for generating bioactive assemblies and uses thereof |
| 04/23/2009 | WO2007044534A3 Vegf analogs and methods of use |
| 04/23/2009 | WO2007041610A3 Genes and proteins associated with angiogenesis and uses thereof |
| 04/23/2009 | WO2007041360A3 Peptides and calcium regulation in mammalian cells |
| 04/23/2009 | WO2007038762A3 Penumbra nucleic acid molecules, proteins and uses thereof |
| 04/23/2009 | WO2007037669A3 Compositions for prevention and treatment of infections caused by eimeria parasites in animals |
| 04/23/2009 | WO2007030658A3 Compositions useful for and methods of modulating angiogenesis |
| 04/23/2009 | WO2007028147A3 Identification of a prostatic intraepithelial neoplasia (pin)-specific gene and protein (pin-1) useful as a diagnostic treatment for prostate cancer |
| 04/23/2009 | WO2007019426A3 A novel peptide involved in energy homeostasis |
| 04/23/2009 | WO2007005645A3 Materials and methods for the generation of fully 2'-modified nucleic acid transcripts |
| 04/23/2009 | WO2006133333A3 Stimulation of pancreatic b cell proliferation |
| 04/23/2009 | WO2006107387A3 Wound treatment device for photodynamic therapy and method of using same |
| 04/23/2009 | WO2006105538A3 Methods and compositions for treating il-21 related pathologies |
| 04/23/2009 | WO2005100384A3 Ai-2 compounds and analogs based on salmonella typhimurium lsrb structure |
| 04/23/2009 | WO2005097205A3 Dna virus microrna and methods for inhibiting same |
| 04/23/2009 | WO2005077084A3 Krüppel-like transcriptional factor klf4/gklf and uses thereof |
| 04/23/2009 | WO2005072056A3 Hsp therapy in conjunction with a low antigenicity diet |
| 04/23/2009 | WO2005032399A3 Il4 receptor antagonists for horse, dog and cat |
| 04/23/2009 | WO2004028479A9 Nouvelles compositions et methodes de traitement du psoriasis |
| 04/23/2009 | US20090106857 Maize Stress-Responsive NAC Transcription Factors and Promoter and Methods of Use |
| 04/23/2009 | US20090106854 Polyubiquitin Rubi3 Promoter and 5' Regulatory Sequences |
| 04/23/2009 | US20090105464 Physiologically active polypeptide and dna |
| 04/23/2009 | US20090105463 Compositions of and Methods of Using Oversulfated Glycosaminoglycans |
| 04/23/2009 | US20090105462 Glycosylated erythropoietin |
| 04/23/2009 | US20090105459 Novel hemopoietin receptor protein, nr12 |
| 04/23/2009 | US20090105458 Novel hemopoietin receptor protein, nr12 |
| 04/23/2009 | US20090105457 Novel hemopoietin receptor protein, nr12 |
| 04/23/2009 | US20090105456 Porous keratin construct and method of making the same |
| 04/23/2009 | US20090105455 Purified interleukin-15/fc fusion protein and preparation thereof |